New Long-Acting painkiller could cut opioid use after keyhole surgery
NCT ID NCT07458256
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a long-acting numbing drug (liposomal bupivacaine) plus standard bupivacaine works better than standard bupivacaine alone for pain after laparoscopic surgery. About 190 adults having gallbladder, hernia, or appendix surgery will receive one of the two treatments. The goal is to see if the combination reduces the need for rescue pain medication within 48 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
liposomal bupivacaine plus bupivacaine hydrochloride
What this could lead to
If it works, this could provide longer-lasting pain relief after laparoscopic surgery, reducing the need for opioid painkillers.
What could go wrong
This is a mid-sized trial (190 people) comparing two local anesthetics, so any benefit may be modest. Results may not apply to other surgeries or pain types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCAL INFILTRATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••